Fact CheckerSign in

NCT04349475Active, not recruiting

Therapeutic Omegas for Triglyceride Suppression

Pilot RCT Intervention Targeting Elevated Triglycerides With a Point-of-Care Meter and Omega-3 Fatty Acids to Normalize Triglycerides and Fetal Growth

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Brief summary (registry, in English)

This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are \~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
13 Apr 2020
Start date
29 Nov 2021
Primary completion date
30 Apr 2026
Lead sponsor
University of Colorado, Denver
NCT number
NCT04349475

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 29 Nov 2021 to the primary completion date, 30 Apr 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Chronic steroid use

Other illness

  • Pre-gestational diabetes or prediabetes
  • History of gestational diabetes,
  • History of pre-eclampsia, spontaneous pre-term delivery, or gestational hypertension \<34wks

Other

  • Tobacco or illicit substance use

Who the study is looking for

  • Pregnant women between the ages of 21-39 yrs
  • Pre-pregnancy BMI 28-39
  • Fasting Triglyceride ≥120 mg/dL measured by 15 wks

Age in the registry: 0 years to 39 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Colorado Anschutz Medical Campus
Coordinator of this site? Confirm its status
AuroraUnited StatesUnknown status
University of Oklahoma Health Sciences Center
Coordinator of this site? Confirm its status
Oklahoma CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.